Corvus Pharmaceuticals (CRVS) Stock Price & Financial Analysis
Corvus Pharmaceuticals Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Corvus Pharmaceuticals
What is the current stock price for CRVS?
As of the latest trading session, CRVS stock trades at $14.69. The 52-week range is $2.54–$26.95, with a day range of $13.92–$14.80.
What is the P/E ratio for CRVS?
The P/E ratio (Price-to-Earnings) for CRVS is shown in the Key Statistics section. This valuation metric helps compare Corvus Pharmaceuticals, Inc. to industry peers.
Does CRVS pay dividends?
Corvus Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for CRVS?
Based on 4 analysts, the consensus for CRVS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of CRVS?
Corvus Pharmaceuticals's market capitalization is $1.22B, classifying it as a small-cap company. Corvus Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.